What is the role of steroids, such as prednisolone, in the treatment of pediatric patients with Kawasaki disease, particularly those at high risk of developing coronary artery aneurysms or who are unresponsive to initial treatment with intravenous immunoglobulin (IVIG) and aspirin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the role of steroids, such as prednisolone, in the treatment of pediatric patients with Kawasaki disease, particularly those at high risk of developing coronary artery aneurysms or who are unresponsive to initial treatment with intravenous immunoglobulin (IVIG) and aspirin?
What is the role of steroids in treating Kawasaki disease?
What is Kawasaki disease (Mucocutaneous Lymph Node Syndrome)?
Why are medium-caliber vessels predominantly affected in Kawasaki disease, and what is the molecular pathophysiological explanation?
What is Kawasaki's disease?
What is the recommended dose of spironolactone (lasilactone) in pediatric patients with hypertension or heart failure, considering factors such as age, weight, and renal function?
How to manage a patient with a nasal bone fracture and anterior wall of maxillary sinus fracture?
What is the role of steroids, such as prednisolone, in the treatment of pediatric patients with Kawasaki disease, particularly those at high risk of developing coronary artery aneurysms or who are unresponsive to initial treatment with intravenous immunoglobulin (IVIG) and aspirin?
What is the onset of action of dipyrone (metamizole) in a typical adult patient with no significant medical history, such as impaired renal function or bleeding disorders?
When should unfractionated heparin (UFH) be stopped for thromboprophylaxis in patients at risk for venous thromboembolism (VTE)?
What is the onset of action for intravenous (IV) dipyrone in a patient with severe pain and potentially impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question